Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Exchange Rate Effect (2022 - 2025)

Historic Exchange Rate Effect for Viking Therapeutics (VKTX) over the last 4 years, with Q4 2025 value amounting to $9000.0.

  • Viking Therapeutics' Exchange Rate Effect rose 11216.22% to $9000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$8000.0, marking a year-over-year increase of 9459.46%. This contributed to the annual value of -$8000.0 for FY2025, which is 9459.46% up from last year.
  • Viking Therapeutics' Exchange Rate Effect amounted to $9000.0 in Q4 2025, which was up 11216.22% from -$6000.0 recorded in Q3 2025.
  • Over the past 5 years, Viking Therapeutics' Exchange Rate Effect peaked at $141000.0 during Q4 2022, and registered a low of -$223000.0 during Q3 2022.
  • Its 4-year average for Exchange Rate Effect is -$19142.9, with a median of -$7500.0 in 2023.
  • Per our database at Business Quant, Viking Therapeutics' Exchange Rate Effect soared by 20000.0% in 2024 and then tumbled by 50000.0% in 2025.
  • Viking Therapeutics' Exchange Rate Effect (Quarter) stood at $141000.0 in 2022, then crashed by 64.54% to $50000.0 in 2023, then crashed by 248.0% to -$74000.0 in 2024, then soared by 112.16% to $9000.0 in 2025.
  • Its Exchange Rate Effect stands at $9000.0 for Q4 2025, versus -$6000.0 for Q3 2025 and -$12000.0 for Q2 2025.